title: Induction of the c-ski proto-oncogene by phorbol ester correlates with induction of megakaryocyte differentiation.
abstract: Overexpression of v-ski blocks the terminal differentiation of chicken erythroblasts, and in cooperation with v-sea causes transformation of these cells, indicating that c-ski may play a role in regulating either proliferation or differentiation in hematopoietic cells. We examined c-ski expression in four different myeloid cell lines which can be induced to differentiate by exposure to phorbol 12-myristate 13-acetate (PMA). Two of the cell lines are multipotent and have the ability to differentiate into either erythrocytes or megakaryocytes (K562 and HEL cells), one cell line differentiates exclusively into megakaryocytes (CHRF-288-11), and the fourth cell line differentiates into either monocytes or granulocytes (HL-60). Our findings indicate that c-ski mRNA is up regulated by PMA only in those cell lines which respond by differentiating along the megakaryocyte lineage. The extent of differentiation and the observed increase in c-ski mRNA levels are positively correlated with the PMA concentration used to induce differentiation. Experiments in which CHRF-288-11 cells were treated with the protein kinase C (PKC) activator bryostatin 1 indicate that c-ski mRNA induction is not a general effect of PKC activation. The results strongly suggest that c-ski expression is correlated with megakaryocyte maturation.
authors.affiliation: Department of Moleuclar Genetics, Biochemistry, and Microbiology, University of Cincinnati College of Medicine, Ohio 45267-0524.
authors.forename: S
authors.initials: S
authors.lastname: Namciu
authors.forename: M A
authors.initials: MA
authors.lastname: Lieberman
authors.forename: E
authors.initials: E
authors.lastname: Stavnezer
mesh_terms: D054713:Bryostatins; D002454:Cell Differentiation / Q000187:drug effects; D003470:Culture Media; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007783:Lactones / Q000494:pharmacology; D007947:Leukemia, Megakaryoblastic, Acute; D018942:Macrolides; D008533:Megakaryocytes / Q000378:metabolism / Q000473:pathology*; D008562:Membrane Glycoproteins / Q000378:metabolism*; D015122:Mercaptopurine / Q000031:analogs & derivatives / Q000494:pharmacology; D000090063:Proto-Oncogene Mas; D011519:Proto-Oncogenes / Q000187:drug effects / Q000502:physiology*; D012333:RNA, Messenger / Q000378:metabolism*; D013755:Tetradecanoylphorbol Acetate; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D054713:Bryostatins; D003470:Culture Media; D007783:Lactones; C000715470:MAS1 protein, human; D018942:Macrolides; D008562:Membrane Glycoproteins; D000090063:Proto-Oncogene Mas; D012333:RNA, Messenger; C046785:bryostatin 1; C010149:6-ethylthiopurine; D015122:Mercaptopurine; D013755:Tetradecanoylphorbol Acetate